Netherlands· NL-54d3c539e0a2

Myleran 2 mg filmomhulde tabletten

A busulfan product containing busulfan, registered in Netherlands by Aspen Pharma Trading Limited. The same ATC class is registered in 15 of our 19 countries.

ATC L01AB01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about busulfanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Busulfan is registered in 15 of 19 countries.

Countries holding a registration under ATC L01AB01 (busulfan), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search busulfan products by name

Busulfan · ATC L01AB01

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BUSULFAN
Manufacturer: Aspen Pharma Trading Limited
Country: Netherlands (NL)
ATC code: L01AB01
ATC class: Busulfan
Defined daily dose: 0.224 g, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
00262

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

245 interactions on record for busulfan.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check busulfan against other medicines How interaction checks work

Busulfan · interactions on record

245 records

34 severe
141 moderate
16 minor
54 info

Most severe, free to view

Nalidixic acidJ01MB02severe
MetronidazoleJ01XD01severe
ThiotepaL01AC01severe
CladribineL01BB04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Busulfan in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All busulfan products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Busulfan Accord, Myleran
Belgium · Myleran
Czechia · Myleran
Germany · Busulfan Accord, Busulfan Koanaa
Denmark · Busulfan Zentiva
Estonia · Myleran
Spain · Busulfano Accord, Busulfano Aspen
France · Busulfan Accord, Busulfan Koanaa
United Kingdom (Northern Ireland) · Busulfan Accord, Busulfan Aspen Pharma Trading Limited
Greece · Busulfan Bioars
Croatia · Busulfan Pliva
Hungary · Busulfan Accord, Busulfan Teva
Ireland · Myleran
Iceland · Busulfan Fresenius Kabi, Myleran
Italy · Busulfan Accord, Busulfan Tillomed
Liechtenstein · Busulfan Fresenius Kabi
Lithuania · Myleran
Luxembourg · Myleran
Norway · Busulfan Fresenius Kabi
Poland · Busulfan Accord, Busulfan Zentiva
Portugal · Bussulfano Accord, Myleran
Romania · Busulfan Accord, Myleran
Sweden · Busulfan Zentiva, Myleran
Slovakia · Myleran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ad5662fe-a56d-449b-a93a-98f15189ef28
GET /v1/drugs/ad5662fe-a56d-449b-a93a-98f15189ef28?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h00262_smpc.pdf",
  "strength": null,
  "atc_label": "Busulfan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg00262",
  "excipients": [
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 0-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "BUSULFAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h00262.pdf",
  "authorised_at": "1968/04/03",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "00262",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about busulfan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console